Seoul, South Korea · Founded 2017 · Privately Held (backing)
Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. ExoCoBio is based in Seoul, South Korea and was founded in 2017. Its last known valuation is $510,000. It has raised $55.3 million.
Last price · $/share
—
Implied valuation
$510K
Total raised
$55.3M
Last round
—
Cap table — not yet on record
ExoCoBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ExoCoBio with a free account
·The complete investor list: 20 names
·Watch ExoCoBio: the Monday email on marks, rounds and moves
